News Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today…Super UserMay 16, 2022
News Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa ROCKVILLE, Md., May 16, 2022 /PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO)…Super UserMay 16, 2022
News Sponsored Deloitte: Why now could be a great time to start preparing for an IPO | Crain’s New York Business No question about it—2021 was a banner year for initial public offerings. Nasdaq data indicates…Super UserMay 16, 2022
News The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in the Netherlands (Europe),…Super UserMay 16, 2022
News IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation to Scale Blockchain-secured…Super UserMay 13, 2022
News Another Federal Regional Cluster Funding Opportunity Emerges By: Brian Darmody, Chief Strategy Officer, AURP: Building Communities of Innovation May 10, 2022 Sometime…Super UserMay 12, 2022
News QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | Business Wire HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today…Super UserMay 12, 2022
News Qiagen N.V. – QIAGEN acquires majority stake in enzymes provider BLIRT S.A. HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced…Super UserMay 12, 2022
News Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia Gravis - Data Presentation Today at 14th Myasthenia Gravis Foundation of America International Conference on Myasthenia…Super UserMay 12, 2022
News Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform The cloud platform will empower biotech companies and CROs with an integrated solution for clinical…Super UserMay 12, 2022